← Back to headlines
Truist Maintains Buy Rating on Intuitive Surgical
Truist has reiterated its 'Buy' rating for Intuitive Surgical (ISRG), indicating continued confidence in the company's stock performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
